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Generation of Skin Substitutes for the Treatment of Burns
Amy Li1, Bronwyn Dearman1 and John Greenwood1,2 1Skin Engineering Laboratory, IMVS/
Hanson Institute, Adelaide, Australia, 5000; 2Burns Unit, Royal Adelaide Hospital, Adelaide,
Australia, 5000
The use of skin substitutes to facilitate wound closure has significantly improved the survival rate
of patients with insufficient donor skin for autografts. These skin substitutes can be categorised
into three classes: (1) cultured epidermal sheets or suspensions; (2) dermal replacements
consisting of a biosynthetic matrix with/without fibroblasts, and (3) two-layered constructs
comprising a combination of skin cells in a matrix. These substitutes are available commercially
or are produced locally by hospital laboratories. The Skin Engineering Laboratory (SEL) of the
Burns Unit, Royal Adelaide Hospital is one such laboratory and is the first laboratory in Australia
to be licensed by the Therapeutic Goods Administration to produce cultured keratinocytes for
clinical use. This Autologous Cultured Keratinocytes for Transplantation (ACKT) process is
performed entirely in Class 350 cleanrooms in a facility with an established quality control system
to ensure product quality and safety. ACKT has been used successfully in 14 major (450% of total
body surface area (TBSA) burns cases and provided sufficient numbers of cells to cover 4 100%
TBSA per patient.
The establishment of the cultured skin cell service is the first step towards the generation of
wound healing and skin regenerative products by SEL. Our primary aim has always been to
develop skin substitutes that closely approximate autologous skin. We report on the potential use
of a novel family of polyurethanes, NovoSorb
TM
, as the scaffold for skin substitutes. These
Biodegradable Temporising Matrices (BTMs) are engineered to have the required mechanical
properties of skin and demonstrate high biocompatibility with keratinocytes, dermal fibroblasts
and microvascular endothelial cells in vitro and in vivo studies. Furthermore, preliminary studies
show BTM reduced wound contraction and supported reepithelialisation when transplanted onto
full thickness wounds in sheep. Cell infiltration studies and construction of skin substitutes using
BTM are currently underway.
A New Role for Pericytes in Promoting Epidermal Regeneration
Pritinder Kaur, Sophie Paquet-Fifield, Pradnya Gangatirkar, Amy Li and Tara MacDonald
Epithelial Stem Cell Biology Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia
Epidermal stem and progenitor cells of the skin interact with their stromal microenvironement to
regulate epithelial tissue renewal and maintenance. However, the precise molecular and cellular
components that form the microenvironment of keratinocyte stem cells and their progeny remain
poorly defined. Recent studies in our laboratory have provided insight into the role of the
extracellular matrix component laminin-10/11 in promoting skin tissue regeneration. In addition
we identified a functionally relevant subset of human dermal cells identified by the antibody
HDF-1, (HDF-1bri cells), which secrete soluble factors that promote human skin regeneration.
In this study we have sought to determine the identity, location and molecular profile of HDF-1bri
cells using microarray technology with the specific goal of identifying functional molecular
regulators provided by these cells that may act to promote skin regeneration, while providing new
markers for this functionally relevant subset of dermal cells. The gene expression profiling data
reveal that HDF-1bri cells preferentially express various mediators of epithelial-mesenchymal
interactions at the m-RNA level, including growth factors, extracellular matrix proteins and
signalling molecules including the Notch pathway recently implicated in stem cell regulation.
Further, new cell surface markers that identify the HDF-1bri cells have also been identified. These
data provide the basis for the functional analyses of molecular regulators that promote the
proliferative and tissue regenerative ability of keratinocyte stem cells and their progeny with the
long-term aim of developing improved therapeutics for human skin replacement.
Flightless 1: A Novel Target for Improving Wound Repair
Allison J Cowin Child Health Research Institute, 72 King William Road, North Adelaide, SA
The actin cytoskeleton is integrally involved in cellular processes including adhesion, migration
and proliferation all essential processes for wound repair. Our studies investigating Flightless 1
(Flil), a highly conserved actin-remodelling protein, now reveal that Flil is an important regulator
of wound repair whose manipulation may lead to enhanced wound outcomes. Using Flil deficient
(þ /) and Flil transgenic mice we have investigated the effect of differential Flil gene expression
on wound healing. Flil deficient (þ /) mice are characterised by improved wound healing and
enhanced reepithelisation. In contrast, Flil over expressing mice have significantly impaired
wound healing with reduced cellular proliferation and delayed epithelial migration. Although Flil
was thought to be solely an intracellular protein we have new evidence showing that it is secreted
in response to wounding. We have now generated and tested a panel of affinity purified mouse
polyclonal antibodies raised against different parts of the Flil peptide and have shown that they
can modulate Flil activity in vitro. Intradermal application of one of these antibodies (aFlil) to
murine incisional wounds significantly enhances wound healing showing that modulation of Flil
directly affects wound repair outcomes. We have further investigated how Flil may modulate
wound repair by studying its effects on two growth factors known to be important in fibrosis and
scar formation. TGF-b1 expression is decreased in Flil deficient wounds whilst TGF-b3 is
enhanced. This ratio of low TGF-b1:high TGF-b3 could contribute to the enhanced healing
observed in Flil deficient mice. Additionally, when Flil gene expression was knocked down by
over 90%, using siRNA a significant decrease in Smad2 and 3 gene expression was observed yet
inhibitory Smad7 was significantly elevated. We have also investigated the effect of Flil on the AP-
1 proteins c-fos and c-jun and found that when Flil levels were reduced by siRNA for 30 minutes,
both c-fos and c-jun mRNA were significantly decreased compared to controls. Our studies have
shown that Flil is a potentially important mediator of wound repair via mechanisms involving cell
migration and proliferation. Additionally, Flil may modulate TGF-b gene expression via regulation
of AP-1 and signalling via the Smad pathway. Understanding these important processes will help
to identify new targets for modulating Flil activity thereby leading to potential new mechanism-
based wound and anti-scarring therapies.
Snail Transcription Factors Down-regulate Keratinocyte Differentiation Genes
JG Lyons1,2, V Patel2 and JS Gutkind2 1Dermatology Research Labs, University of Sydney, and
Sydney Head & Neck Cancer Institute, RPA Hospital, Camperdown NSW, Australia; 2Oral and
Pharyngeal Cancer Branch, NIDCR, NIH, Bethesda MD, USA
Background: The Snail family of zinc finger transcription repressors is known to induce an
epithelial mesenchymal transition (EMT) in epithelial cells and are over-expressed in squamous
cell carcinomas. A prominent target of Snail is E-cadherin, a cell-cell adhesion protein that is
important in maintaining polarity and a differentiated epithelial phenotype. It has been reported
that stable transfection of MDCK kidney epithelial cells with a Snail-expression vector is sufficient
to confer tumorigenicity and invasiveness on them. However, recent reports also have shown that
re-expression of E-cadherin from a Snail-insensitive promoter is not sufficient to reverse the EMT
in Snail-expressing cells. The full complement of genes targeted by Snail in keratinocytes are not
known.
Method: In order to identify other Snail target genes that are important to EMT, we have
developed a tamoxifen-inducible Snail model based on the well characterized MDCK cell line. A
chimeric gene was made by fusing human Snail-1 at its C-terminus to ERT2, a mutant form of the
human estrogen receptor that is inducible by tamoxifen. This inducible model was validated as
accurately recapitulating Snail up-regulation in epithelial cells using MDCK cells, and then
applied to keratinocytes of both head & neck and skin origin to identify target genes in those cells,
using cDNA microarrays.
Results: As well as epithelial-specific cell-cell adhesion protein-encoding genes, several genes
with critical roles in terminal differentiation of keratinocytes were demonstrated to be down
regulated by Snail.
Conclusion: The genes identified suggest that Snail may contribute to tumour pathogenesis by
preventing terminal differentiation, as well as increasing invasion of extracellular matrix.
2688 Journal of Investigative Dermatology (2007), Volume 127
Abstracts
Visualising Dendritic Cell Responses in the Skin
Lai Guan Ng and Wolfgang Weninger The Wistar Institute, University of Pennsylvania,
Philadelphia, USA and the Centenary Institute, University of Sydney, Sydney, Australia
The skin harbours specialised subsets of innate immune cells, including epidermal Langerhans
cells (LC), dermal dendritic cells (DDC) and dermal macrophages. These cells are believed to
regulate cutaneous immuno-surveillance by virtue of detecting invading microbes, and
transporting them to draining lymph nodes. Despite these important activities, we have little
understanding of the spatio-temporal orchestration of cutaneous innate immunity. We made use
of a newly-developed intravital two-photon microscopy model in mouse skin in order to visualise
the behaviour of LC and DDC at the single cell level in real time within their natural
microenvironment. To this end, we employed transgenic mice in which the enhanced yellow
fluorescent protein (YFP) is driven under the control of the CD11c promoter, In the steady-state,
LC were found to be immobile, with only occasional extensions and retractions of their dendrites.
In stark contrast, DDC were actively crawling through the dermal interstitial space, suggesting
active immuno-surveillance at this site. Upon challenge of mice with endotoxin, DDC underwent
remarkable shape change as evidenced by their elongation, and decreased motility. These
alterations persisted for approximately three hours. After six hours, DDC resumed migratory
behaviour at a level comparable to untreated mice. In order to further analyse their
immunosurveillance function, fluorescently-tagged Leismania major parasites were injected
intradermally. Interestingly, we found that some of the parasites moved freely through the
extravascular space. However, we also observed vacuolisation of YFPþ DDC shortly after
parasite injection, indicating active infection of these cells. Taken together, we have defined a
microanatomical localisation specific migratory behaviour of DC in the skin. In the case of DDC,
this enables the cells to rapidly encounter intruding pathogens, which represents the earliest step
of cellular innate immune responses.
Differences in MHC Expression Between Melanocytes of the Hair Follicle and
Epidermis
Dinh HV1,2, Meyer KC3, McCluskey J2, Sinclair RD1,4 and Paus R3 1Department of Dermatology,
St Vincent’s Hospital, Melbourne; 2Department of Microbiology & Immunology, The University
of Melbourne, Parkville; 3Department of Dermatology, University Hospital Schleswig-Holstein,
Lu¨beck, Germany; 4Department of Medicine (Dermatology), The University of Melbourne,
Parkville, Australia
The anagen hair bulb is one of the few sites of immune privilege (IP) in mammalian tissues1. A
collapse in hair follicle IP, with increased expression of major histocompatibility complex (MHC)
class Ia and MHC class II, is thought to be the mechanism behind alopecia areata (AA)2 resulting
in patches or widespread areas of alopecia. In contrast, the autoimmune attack seen in vitiligo
results in depigmented skin. Despite a common autoimmune target, the melanocyte, these two
diseases are infrequently co-expressed and rarely co-localised. As such, we hypothesized that
there must be fundamental antigenic differences between melanocytes of the skin and those of the
hair follicle. In order to examine ex-vivo expression of MHC antigens on melanocytes of the hair
follicle and epidermis, we performed double immunofluorescent staining on scalp cryosections
from normal subjects with either w6/32 or CR3/43 and NKI/beteb recognizing MHC-Ia or MHC-II
expression and melanocytes respectively.
We found that anagen hair follicle melanocytes residing above the apex of the dermal papilla do
not express MHC-Ia or MHC-II. Epidermal melanocytes however, do express MHC-II. The
expression of MHC-Ia on epidermal melanocytes could not be conclusively determined. Due to
the strong staining with w6/32 by epidermal keratinocytes, NKI/beteb-labeled melanocytes could
not be accurately identified through double-staining. Our finding of a contrasting MHC
expression pattern between these anatomically distinct melanocyte populations may further our
understanding why hair follicle melanocytes are preferentially attacked in alopecia areata
whereas epidermal melanocytes are the target in vitiligo.
1 Paus R, Nickoloff B, Ito T. A ‘hairy’ privilege. Trends Immunol. 2005;26:32-40; 2 Paus R, Ito
N, Takigawa M, Ito T. The hair follicle and immune privilege. J Invest Dermatol Symp Proc.
2003;8:188-94
A Characterisation of iNKT Cells in Mouse Skin
Kirsten Hammond, Carling Chan and Gary Halliday Dept of Dermatology, Sydney University
‘Invariant’ (i) NKT cells are an evolutionarily conserved T cell subset that use a single T cell
receptor (TCR) a chain (V a14J a18 in mice; V a24J a18 in humans) combined with a limited
repertoire of TCR b chains. The highly restricted TCR repertoire of iNKT cells recognises
glycolipid antigens presented by the antigen-presenting molecule CD1d, which immediately
distinguishes them from most other a b T cells that recognise peptides in conjunction with major
histocompatibility complex (MHC) class I or II molecules. iNKT cells have the ability to
powerfully influence immune responses due to their capacity to rapidly produce copious amounts
of immuno-modulatory cytokines.
Here we report for the first time the direct identification of iNKT cells isolated from normal mouse
skin. We used a highly specific reagent, aGalCer-loaded CD1d tetramers, and flow cytometry to
detect these cells. This observation has important implications for skin immunity – for example, a
glycolipid extracted from Borrelia burgdorferi, the causative agent of Lyme disease which infects
humans through deer tick bites, has recently been found to stimulate iNKT cells. In addition, iNKT
cells have been implicated in the mechanism by which ultraviolet (UV) radiation from sunlight
suppresses the immune system – a significant contributing factor in the development of skin
cancer induced by UV radiation. Our novel findings, that iNKT cells are present in skin in large
numbers, indicate that these cells may represent major mediators of skin immunity.
Investigating the Role of UV-Activated Cell Signalling Pathways in TNFa released
from Keratinocytes
Visalini Muthusamy, Toulla Koumakis and Terrence J PIVA School of Medical Science, RMIT
University, Plenty Road, Bundoora, Victoria
Background: UV exposure causes direct DNA damage resulting in multiple mutations as well as
suppressing the body’s immune system. Mutated genes have a role in pro-tumour activities that
can lead to the development of skin cancer. However, before UV radiation on gene expression
can be elicited, signalling pathways first need to be activated. There are three major signalling
pathways in the cell which are activated by UV radiation; p38 MAPK, JNK and NF-kB pathways.
It is unknown as to which pathway plays a major role in UV-induced TNFa release from skin cells.
Method: The human keratinocyte cell line, HaCaT, and squamous cell carcinoma cell line,
Colo16 were exposed to UV (A, B and combinations thereof) radiation and changes in the cellular
expression of p38 MAPK, JNK and NF-kB pathway intermediates over a 24 h period were
measured using Western blots. TNFa levels in the culture media were measured using ELISA kits.
Results: Cell cultures were exposed to either UVA (2000 and 20000 Jm2) and/or UVB (200 and
2000 Jm2) radiation. Colo 16 cells were more sensitive to high dose UVB and UVAþB radiation
than were HaCaT cells, though neither cell line was sensitive to UVA radiation at the doses tested.
Of interest was the finding that in both HaCaT and Colo 16 cells, the increase and decrease of
IeˆBa´ levels which indicated the inactivation and activation of NFeˆB was observed at different time
points over the 24 h time period.
Conclusion: The results obtained from these studies, show that UV radiation activates different
responses in HaCaT and Colo 16 cells. In both cell lines, UVB and UVAþB radiation appear to
be more detrimental than does UVA. While HaCaT cells are used by many as a model for
keratinocyte biology, their role in cell signalling studies needs to be re-evaluated as they contain
deficiencies in some signalling and cell cycle intermediates [1].
1 Chaturvedi V, Qin JZ, Denning MF, Choubey D, Diaz MO, and Nickoloff BJ. (2001) J
Dermatol Sci 26:67-78.
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Comparison of the Immune Suppressive Effectiveness of UVB and Long-wave UVA
in Humans
Y Renwick, T Phan, G Halliday and D Damian Department of Dermatology, Melanoma and Skin
Cancer Research Institute, Sydney Cancer Centre, The University of Sydney at Royal Prince Alfred
Hospital
Background: Ultraviolet radiation (UVR)-induced suppression of cutaneous immune responses
enhances the development of skin cancers. We determined the immune suppressive effectiveness
of various narrow bandwidths across the UVR spectrum in order to calculate the relative
immunosuppressive contribution of UVB (290–320 nm) and UVA (320–400 nm) in sunlight.
Method: We recruited groups of healthy, nickel-allergic female volunteers. Using a filtered xenon
arc lamp, we exposed discrete areas of skin on the lower back of volunteers to graded doses of
narrowband UVR. Adjacent, unirradiated areas of skin served as immunologically intact control
sites. Following UVR exposure, nickel patches were placed on each of the irradiated and
unirradiated sites. The intensity of nickel contact hypersensitivity responses at each site was then
measured with a reflectance erythema meter as nickel-induced erythema (NIE) 72 hours later. The
degree of immunosuppression was calculated by comparison of the NIE of irradiated sites to the
NIE of control unirradiated sites.
Results: The UVB wavelengths 290–310 nm caused significant dose-responsive immunosuppres-
sion at suberythemal doses. The UVA wavelengths 360–380 nm were also immunosuppressive at
exposures equivalent to only 15 minutes of Spring midday sun in Sydney, with loss of the effect at
higher exposures.
Conclusion: There are two peaks in the action spectrum for immunosuppression in humans with
fundamental differences in the dose-response characteristics between these peaks. UVA is
approximately 20 times more abundant in solar radiation than UVB and therefore contributes
relatively more to the immunosuppression that occurs following brief exposures.
Unlocking the Inductive and Stem Cell Potential of Hair Follicle Mesenchyme
Colin Jahoda Durham University, United Kingdom
The hair follicle dermis/mesenchyme has well-established inductive potential in which skin
epidermis can be induced to form hair follicles. There is also evidence that under their influence
other epithelia, including corneal epithelium from the adult eye, can be reprogrammed into skin
and follicles. Dermal stem cell activity has been recognized for some time in the context of
experimental follicle regeneration and wound healing, however more recently a much broader
stem cell potential has emerged. Follicle dermal cells are also able to support other stem cells in
an undifferentiated state. These findings have raised interesting therapeutic possibilities, as well as
some intriguing biological questions concerning the relationship between induction and stem cell
activitie
Recessive Epidermolysis Bullosa Simplex due to a Homozygous Truncation
Mutation KRT14 Y204X with Basal K6/16 Expression and an Ameliorating
Phenotype
Linda Martin1, Eleni Yiasemides1, Niken Trisnowati1,4, John Su2, Sandra Klingberg3, Penelope
Marr4, David Orchard2, George Varigos2 and De´de´e F Murrell1,5 1Department of Dermatology, St
George Hospital, Sydney; 2Royal Children’s Hospital, Melbourne; 3Chemistry Laboratory, Royal
Brisbane Hospital; 4Dept of Anatomical Pathology, St George Hospital; 5The University of NSW,
Sydney
Background: Epidermolysis bullosa simplex (EBS) is usually inherited as an autosomal dominant
trait due to mutations in either KRT5 or KRT14. Recessive EBS is extremely rare and only 6
previous mutations in KRT14 have been described, and others in PLEC1. Here we present the first
Australian patient diagnosed with recessive EBS due to KRT14 Y204X and compare the phenotype
with the previous cases of R-EBS.
Case Report: A female child of consanguineous parentage was noted at birth to have aplasia cutis
affecting the palms and soles. Blistering worsened and she had failure to thrive and anaemia when
very young which gradually improved with age. At 8 years she had scattered blisters, mucosal
involvement, palmoplantar hyperkeratosis, hyperkeratotic nails, pruritus, epidermolysis bullosa
(EB) naevi and atrophic scarring.
Results: Electron microscopy demonstrated blistering in the basal layer consistent with
epidermolysis bullosa simplex (EBS). Keratin tonofilaments were absent in the basal layer,
however normal keratin filaments were observed in the stratum spinosum and above.
Immunofluorescence mapping was negative for K14, and, unusually, was positive for K6 and
16. Mutation screening identified a homozygous truncation mutation, KRT14-Y204X.
Conclusion: Keratins 5 and 14 are obligate heterodimers and interact to form the intermediate
filament cytoskeleton, which is essential for maintaining the integrity of the basal epidermis. The
KRT14-Y204X mutation is predicted to destabilise mRNA, resulting in nonsense-mediated decay
of K14. The proband’s phenotype was relatively mild considering that no K14 protein was
expressed in her skin. Keratin 6 and 16, which are generally only present in hyperproliferative
disorders were expressed in her epidermis. It is proposed that expression of these keratins
compensates for the loss of K14, and attenuates disease phenotype.
Novel and Recurrent Mutations in KRT5 and KRT14 in Epidermolysis Bullosa
Simplex in Australia
Wen Fei Yan1, Sandra Klingberg2, Lyn Lloyd2, Niken Trisnowati1, Anne Turner3and Dedee F
Murrell1,3 1Department of Dermatology, St George Hospital, University of NSW, Sydney,
Australia; 2Chemistry Lab, Royal Brisbane Hospital, Brisbane, QLD, Australia; 3Multidisciplinary
EB Clinic, Sydney Children’s Hospital, Sydney, NSW
Background: Epidermolysis bullosa simplex (EBS) is a group of heritable blistering skin disorders
caused mostly by mutations in the keratin genes KRT5 and KRT14. EBS has been divided into four
subtypes according to the clinical severity and distribution of the lesions.
Methods: EBS was clinically diagnosed and confirmed by transmission electron microscopy and
immunofluorescence mapping examination of a skin biopsy. Genomic DNA was extracted from
peripheral blood leucocytes and mutation analysis of KRT5 and KRT14 was performed by direct
sequencing in Australian patients.
Results: We have diagnosed 32 EBS families and screened 22 of these for KRT5 and KRT14
mutations. 8 mutations were identified in KRT14 and 4 in KRT5 and 2 mutations in KRT5
combined with KRT14. 11/22 were sporadic cases. In 8 cases, no mutations were found. 7
mutations had not been previously published when identified, including KRT14 M119T, M119V,
M272T and KRT5 E168D, 429delRNKLA, D197E, K199N.I n addition, we got 13 cases with
autosomal dominant inheritance, and 1 case with recessive type. Thus far, none have been used
for pre-natal diagnosis.
Conclusions: All mutations with severe clinical manifestations (clinically classified as EBS-DM)
cluster in the highly conserved ends of the alpha-helical rod domain (HIP,HTP). However, not all
mutations present in hotspots result in EBS-DM. Even different amino acid substitutions at the
same locus and the same mutation can also lead to different clinical severities. Moreover, most of
our patients are improving with age, even in EBS-DM cases. This suggests that there are some
disease-modifying genes in EBS or other protein interactions which play an important role. This
area requires further research as manipulation of these genes could potentially ameliorate the
phenotype earlier.
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Review of Collagen VII Mutations Found in Australian Patients with Dystrophic
Epidermolysis Bullosa Reveals 9 Novel COL7A1 Mutations
Ningning Dang1,4, Sandra Klingberg2, Anne Turner3 and Dedee F Murrell1,4 1Department of
Dermatology, St George Hospital, Sydney, NSW, Australia; 2Department Chemical Pathology,
Royal Brisbane Hospital, Brisbane, QLD, Australia; 3Department Genetics, Sydney Children’s
Hospital, Sydney, NSW, Australia; 4The University of New South Wales, Sydney, NSW, Australia
Introduction: Dystrophic Epidermolysis bullosa (DEB) is an inherited skin fragility disorder
whereby blistering occurs in the sub-lamina densa zone at the level of anchoring fibrils (AFs) of
the dermo-epidermal junction1. It is inherited in both an autosomal dominant (DDEB) and an
autosomal recessive manner (RDEB). Both RDEB and DDEB result from mutations in the type VII
collagen gene (COL7A1).
Method: Skin biopsies from patients were processed for IF antigen mapping. Where there were
sub-lamina densa splits and/or a reduction or negative Collagen VII antibody staining, the
COL7A1 genes were screened for mutations. A review of known mutations of the type VII
collagen gene and the genotypes and phenotypes of the patients with DEB was undertaken.
Results: We report 15 Australian families with different forms of dystrophic epidermolysis bullosa
(DEB) with 23 different COL7A1 allelic mutations, 9 of which were novel mutations. 4 cases of
RDEB-HS combined two PTC mutations and 3 cases of RDEB-HS combined a PTC in one allele
with a second spice-site or silent glycine substitution mutation in the other allele. G2043R, a de
novo and dominant mutation, was identified again in this study. Four recessive silent glycine
substitution mutations were found, G2775S and G1673R (novel), G1338V (novel) and G2791A.
Family 3 with DDEB combined R27 91W and novel G2210V and had a Pasini phenotype in most
individuals, but two members of the family had severe DDEB pruriginosa. From these 3 prenatal
diagnoses have been performed.
References
1 Gardella R, Castiglia D, Posteraro P et al. Genotype-phenotype correlation in Italian patients
with dystrophic epidermolysis bullosa, J Invest Dermatol 2002; 119; 1456-62
2 Whittock NV, Ashton GH, Mohammedi R et al. comparative mutation detection screenting
of the type VII collagen gene (COL7A1) using the protein truncation test, fluorescent
chemical cleavage of mismatch, and conformation sensitive gel electrophoresis. J Invest
Dermatol 1999; 113; 673-86
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Analysis of the Estrogen Receptor Beta Gene, ESR2, In Female Pattern Hair Loss
L Yip1,2, S Harrap2, R Sinclair1 and J Ellis2 1Department of Dermatology, St Vincent’s Hospital,
Melbourne and The University of Melbourne; 2Department of Physiology, The University of
Melbourne
Background: Female pattern hair loss (FPHL) has a polygenic mode of inheritance with an
unproven relationship with androgens. The genes involved in its pathogenesis remain unknown,
but are likely to include genes related to the androgen and estrogen pathways. The ESR2 gene is
located on chromosome 14q22-24 and codes for the estrogen receptor beta (ER-aˆ). In contrast to
ER-a´, ER-aˆ is the predominant subtype within the outer root sheath and epithelial matrix, making
it likely that the ESR2 gene directly modulates the hair growth cycle. This study aims to evaluate
the relationship between ESR2 gene variants and FPHL.
Method: Allele and genotype frequencies of tag single nucleotide polymorphisms (tag SNPs) in
the ESR2 gene were compared between 150 cases with FPHL (stage 3 or greater) and 90 controls
(aged450 years with no hair loss conditions), using w2-tests. Tag SNPs are representative variants
in a region of linkage disequilibrium, whereby their examination would be sufficient to capture
the genotypic information of all known SNPs in that region.
Results: Three ESR2 tag SNPs that collectively capture 33 SNPs in the gene have been analysed
and there were no significant differences in allele or genotype frequency between cases and
controls (P40.1).
Conclusion: By essentially examining 33 SNPs located in the ESR2 gene region, we have been
unable to identify genetic association between ESR2 and FPHL. However, the association of this
gene with FPHL cannot yet be discounted. We are currently analyzing the remaining tag SNPs
necessary to capture all known SNPs in the gene region, and are recruiting an additional 275
cases and 400 controls through the Melbourne Collaborative Cohort Study to increase statistical
power of this study.
Is the Mathematical Modelling of Skin Biology of any Use?
Stephen Gilmore, Department of Dermatology, St. Vincent’s Hospital, Victoria, Australia
Although mathematics now occupies centre stage in many aspects of biological investigation –
think of the rise in importance of data analysis in bioinformatics – there remain within the
scientific community reservations about the practical utility of mathematical models in the life
sciences. Here I aim to show, by counter – example, how these reservations are unfounded. I will
first demonstrate how quantitative models can make correct biological predictions, and then
describe how the results of experiments guided by prediction can validate the postulated
biological principles incorporated a priori into the models. Finally, I will argue that the process of
modelling coupled to experiment and observation in an iterative fashion will, by necessity, lead
to a paradigm shift in the investigation of skin disease.
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Donor site dominance in action: transplanted hairs retain their original hair
pigmentation long-term.
Hope V. DINH1, Rodney D. SINCLAIR1,2, Jennifer MARTINICK3 1Department of Dermatology,
St Vincent’s Hospital, Fitzroy, Victoria, Australia 2Department of Medicine, The University of
Melbourne, Victoria, Australia and 3New Hair Clinic, Perth, Western Australia, Australia.
The concept of ’donor dominance’ in hair transplantation refers to autografts which continue to
maintain their integrity and characteristics after transplantation to a new site1. Such hairs may
retain their original texture and rate of growth. Hair transplantation for patients with androgenetic
alopecia rely on this concept of donor dominance for a successful and long-lasting result.
Recently, the concept of ’recipient dominance’ in hair transplantation has been debated. In a
study of patterns after hair transplantation to the scalp and eyebrows in patients affected by
madarosis, Lee et al2 found that the greying rate of hairs approximated the recipient site rather
than the donor site.
We report on the long-term maintenance of follicular pigmentation in transplanted hairs. We
describe two patients affected by both androgenetic alopecia and hair greying in the transplant
recipient area. They were given autografts of normally pigmented hair follicles harvested from the
occipital area. More than one year post-transplantation, their donor hairs have remained
pigmented long-term, despite being implanted in scalp affected by greying. In one patient the
pigmented hairs have remained stable for 10 years. As the process of greying usually affects the
temporal scalp first, then progresses onto the vertex and occiput later, the maintenance of long-
term follicular pigmentation in our patients may be attributable to donor dominance.
(1) Orentreich N. Autografts in alopecias and other selected dermatologic conditions. Ann. N. Y.
Acad. Sci. 1951; 53: 562-8.
(2) Lee SH, Kim DW, Jun JB, Lee S-J, Kim JCL, Kim NH. The changes in hair growth pattern after
autologous hair transplantation. Dermatol. Surg. 1999; 25: 605-9.
A Ten-Year Review of Skin Cancer in 588 HIV-Positive Patients
M J Whitfeld3, S Hungerford3, Dr YQ Bao1, Dr LJ Leow2 Departments of Dermatology at
St Vincents Hospital, Sydney and Beijing Hospital, Beijing1; Austin Health, Melbourne2; and
The Skin & Cancer Foundation Australia, Sydney3
Background: Our aim is to review the types and prevalence of skin cancer among HIV-positive
patients presenting to two dermatology clinics, and identify the association between sun related
skin conditions, skin cancers seen, age, CD4 count and duration of HIV infection.
Methods: This retrospective study reviews 588 HIV-positive patients who attended a
dermatologist’s clinic at the Skin and Cancer Foundation in Darlinghurst, and her private
dermatology office in St. Leonard’s, Sydney Australia. Information obtained for this study
included: age, sex, duration of HIV-infection, CD4 count and viral load at time of first visit, AIDS
status, current treatment and main diagnoses.
Results: 191 (32.48%) patients had one or more skin malignancies, of whom 157(26.70%) had a
sun related skin cancer (SRSC). These included 13 (22.62%), with one or more basal cell skin
cancers (BCC), 48 (8.16%) who had invasive or in-situ SCC, and 7 (1.19%)who had a
melanoma...Actinic keratoses were diagnosed in 149 out of 588 patients (25.34%).. The ratio of
patients with BCC to patients with SCC was 2.77:1, Non-sun related cancers included 31(5.27%)
with KS and 15(2.55%) with anal dysplasia (including AIN and Bowenoid papulosis).
Conclusion: This study highlights the importance of monitoring for SRSC among HIV-patients.
SRSC were associated with an age greater than 40-years and mild HIV-immunosuppression (CD4
count >450 cells/ml). An association between BCC and duration of HIV-infection was identified
(P=0.032, 95%CI: 0.113 to 2.518), but the confounding factor of age makes this difficult to
interpret. KS and anal dysplasia were associated with moderate immune deficiency (CD4 count
between 250-350 cells/ml).
Differential expression of pyloric atresia in junctional epidermolysis bullosa with
novel ITGB4 mutations
Ningning Dang1,8, Sandra Klingberg2, Adam I. Rubin1, Matthew Edwards3, Siegfried Borelli
4,John Relic 5, Penelope Marr6, Kim Tran6,8, Anne Turner 7, Dedee F. Murrell7,8 1Dept of
Dermatology, St George Hospital, Sydney, 2Dept Chemical Pathology, Royal Brisbane Hospital
3Hunter Genetics & University of Newcastle, Australia 4Triemli Hospital, Zurich, Switzerland
5John Hunter Hospital, Newcastle, Australia 6Dept Anatomical Pathology, St George Hospital 7EB
Clinic, Sydney Children’s Hospital 8University of NSW, Sydney
Background: Junctional epidermolysis bullosa with pyloric atresia is an autosomal recessive
blistering disease including lethal and non lethal variants due to mutations in ITGB4 and ITGA6.
Method: Skin biopsies from patients were processed for IF mapping and when staining for integrin
beta 4 or alpha 6 were absent or reduced, ITGB4 was screened for mutations. A review of known
mutations of ITGB4 and the phenotypes of the patients with JEB-PA was undertaken.
Results: 3 novel ITGB4 mutations were identified in 3 families with JEB -PA: two splice-site and
one insertion mutation. Families 1 and 2 with lethal phenotypes were due to combinations of PTC
and missense mutations (658delC/R252C and 3903dupC/G273D, respectively). However, two
cases in our report had no gastrointestinal symptoms or signs of pyloric atresia (PA). (1) Family 2,
infant born at 33/40 weeks, with marked aplasia cutis, especially around the neck, prominent
subcutaneous veins, and dysmorphic facies, who died after 1 day; (2) Family 3, an affected sister
and brother, had only mild skin involvement with blistering on the feet in summertime. Although
both were homozygous for ITGB4 264G-A/3111-1G-A, only the brother had PA.
Conclusion: These results suggest that pyloric atresia is an inconstant feature of the subtype of EB
known as JEB -PA and that another factor must be determining whether the patient presents with
PA or not. It could be that institutions which do not routinely screen IFM for integrin a6b4 staining
in the absence of PA could be missing this form of EB.
(1) Nakano A, Pulkkinen L, Murrell D, Rico J, Lucky A, Garzon M, Stevens CA, Robertson S,
Pfendner E, Uitto J: Epidermolysis Bullosa with Congenital Pyloric Atresia: Novel Mutations
in the B4 Integrin Gene (ITGB4) and Genotype/Phenotype Correlations. Pediatric Research
49:618-626, 2001
(2) Vidal F, Aberdam D, Miquel C et al : Integrin beta 4 mutations associated with junctional
epidermolysis bullosa with pyloric atresia. Nat Genet 1995; 10: 229-234.
Randomised, double-blind, prospective study to compare topical 5-aminolaevu-
linic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy
for extensive scalp actinic keratosis.
F. J. Moloney, and P. Collins*, Melanoma and Skin Cancer Research Institute, Sydney Cancer
Centre, University of Sydney at Royal Prince Alfred Hospital, NSW 2050, Australia, *St Vincent’s
University Hospital, Dublin 4. Ireland
Background: 5-aminolaevlinic acid methylester (MAL) and 5-aminolaevulinic acid (ALA)
photodynamic therapy (PDT) are both effective treatment options for actinic keratosis (AK)s.
While MAL is significantly more expensive than ALA, no studies have directly compared their
efficacy in the treatment of extensive scalp AKs.
Methods: To compare the efficacy and adverse effects of MAL-PDT with ALA-PDT in the
treatment of scalp AKs, 16 male patients aged 59 to 87 with extensive scalp AKs were randomized
into a double-blind, split-scalp prospective study. Two treatment fields were defined (right and
left frontoparietal scalp) and treated two weeks apart. These fields were randomised to receive
either MAL or ALA as first or second treatment. MAL cream was applied for three hours. Twenty
per cent ALA cream was applied for five hours. A blinded observer assessed efficacy comparing
AK counts before and one month after treatment. Pain was assessed using a visual analogue scale
at 3, 6, 12 and 16 minutes.
Results: 15 patients completed treatment to both fields. There was a mean reduction from
baseline in AK counts with the use of ALA of 6.2+/-1.9 as compared to 5.6+/-3.2 with MAL-PDT
(p=0.588). All patients experienced pain which was of greater intensity in the ALA treated side at
all time points: 3 minutes p=0.151, 6 minutes p=0.085, 12 minutes p=0.012 and 16 minutes
p=0.029. Similarly, duration of discomfort post procedure persisted for longer following treatment
with ALA when compared with MAL-PDT (p=0.044)
Conclusion: This study demonstrates that both ALA and MAL-PDT result in a significant reduction
in scalp AKs. There is no significant difference in efficacy. However, ALA is more painful than
MAL-PDT in the treatment of extensive scalp AKs.
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Subcutaneous Injections: What are we doing to our skin?
B.J.Wallace, J.A.Bowler, K-B Tan, S.L.Pett, D.A.Cooper, and M.Whitfeld Department of
Dermatology, St Vincent’s Hospital (Sydney), and the Skin and Cancer Foundation Australia
(Sydney).
Background: Nearly 150 years have passed since the first documented use of subcutaneous
injections was described for mercury compounds to evade the scourge of syphilis. Since this
time, numerous agents for subcutaneous injection have been developed for medicinal,
recreational and cosmetic purposes. Currently, over 66 drugs are available for medicinal use as
subcutaneous injections in Australia and all have been associated with local skin reactions. Some
of these adverse events are well recognised including: insulin (lipoatrophy), vaccines (pain and
swelling), vitamin K (localised sclerodermoid plaques), silicon (siliconomers) and heparin
(localised skin necrosis).
An increasing number of novel biological agents are now being injected subcutaneously as they
are not tolerated orally. These include: interleukin-2 (for the treatment of HIV and numerous
metastatic cancers); beta?interferon (for the treatment of multiple sclerosis and hepatitis C);
etanercept (for the treatment of psoriatic arthritis, psoriasis and rheumatoid arthritis); glatiramer
acetate (for the treatment of multiple sclerosis) and enfuvirtide (an antiretroviral agent for HIV-1
infection).
Case Report: We report four cases in which subcutaneous injections have produced panniculitis
with and without necrosis. These have resulted in atrophy and/or sclerosis caused by very
different physiologic pathways, producing diverse histopathological pictures. These cases include
reactions to beta?interferon, interleukin, enfuvirtide and glatiramer acetate. The significant
reactions described are considerably worse than the reported mild and well tolerated cutaneous
reactions reported by the manufacturers.
Long-term hair repigmentation following a hair transplant for frontal scarring
alopecia
Hope V. DINH1, Rodney D. SINCLAIR1,2, Jennifer MARTINICK3 1Department of Dermatology,
St Vincent’s Hospital, Fitzroy, Victoria, Australia 2Department of Medicine, The University
of Melbourne, Victoria, Australia and 3New Hair Clinic, Perth, Western Australia, Australia.
Hair greying invariably manifests as part of ageing and is considered irreversible. Pigment loss in
canities is due to a reduction or absence of actively melanogenic hair follicle melanocytes in grey
and white hairs respectively. There is also dysfunctional pigment transfer to cortical keratinocytes
as a result of melanocyte degeneration. Amelanotic melanocytes of the mid-to-lower outer root
sheath (including the bulge region) are still present in white hairs but incomplete melanocyte stem
cell maintenance leads to greying1. Repigmentation of grey or white hairs can occur with certain
medical conditions2, usually as a post inflammatory phenomenon, and as a side effect of some
medications. However, most cases of repigmentation are unsustained.
We describe pronounced and long-term repigmentation of white donor hairs in a 57 year old
woman who underwent hair transplant surgery for an area of frontal scarring alopecia secondary
to a burn from childhood. The repigmented hairs have remained stable at more than two years
post transplant. Although repigmentation of hairs is thought to be explained as possibly a post-
inflammatory phenomenon or secondary to altered signally in the hair bulb pigmentary apparatus
after surgery, the mechanisms behind the long-term upkeep of the repigmentation remain elusive.
Further studies focussing on the pathophysiology of the repigmentation mechanisms will advance
the understanding of the greying process. Such studies may also provide insights into strategies to
reverse hair greying in the future.
(1) Nishimura EK, Granter SR, Fisher DE. Mechanisms of hair graying: incomplete melanocyte
stem cell maintenance in the niche. Science 2005;307:720-4.
(2) Shaffrali FCG, McDonagh AJG, Messenger AG. Hair darkening in porphyria cutanea tarda.
Br. J. Derm. 2002; 146:325-9.
Results from a study on the role of Staphylococcus epidermidis in the pustules of
acne rosacea.
N. Gunasingam1,3, M.Whitfeld1,3, L. Leow4, J. Harkness2, S. Hawkins2 1,2Department of
Dermatology and Microbiology, St Vincent’s Hospital and 3the Skin and Cancer Foundation,
Darlinghurst, 4Austin Health, Melbourne
Background: Rosacea is a common skin disease characterised by facial flushing, telangiectasia,
papules and pustules. It is generally regarded as inflammatory in nature. We believe that a
contributory role of bacteria in this condition needs to be revisited, particularly in the light of the
recognition of the role of Propionibacterium acnes in acne vulgaris and the use of topical and
systemic antibiotics as a mainstay in the treatment of rosacea.
Aims: (1) To ascertain whether there is a difference in the bacteria present on the facial skin of
patients with rosacea and those without. (2) To ascertain whether there is a contributory role of
bacteria in the formation of pustules seen in acne rosacea.
Methods: This was a two-party study; the first part being a case-controlled trial with clinically and
historically diagnosed pustular rosacea patients. Bacteria were isolated from the patient’s pustule,
and in addition swabs were taken from the inferior eyelid margin and the facial skin near the
pustule that was incised. This was then compared to swabs taken from controls. The second part,
a cross-sectional analysis, involved comparing the type of bacteria isolated from the patient’s
pustule to the type of bacteria isolated from the skin swab of the same case. Specimens were
cultured aerobically and anaerobically. Speciation as well as antibiotic sensitivity of all pure
growths of staphylococci isolates was performed.
Results: (1) There was no significant difference in the type of bacteria isolated from the skin of
cases and skin of controls (Micrococcus: p = 0.143, Diphtheroids: p = 0.136, Staphylococcus: p =
0.439 and P.acnes: p = 0.273). (2) There was a statistically significant difference in the type of
bacteria isolated from the pustule of cases compared with the bacteria isolated from the skin of
the same case. Nine out of fifteen pustule lesions cultured pure growth of Staphylococcus
epidermidis, whereas all fifteen-skin swabs cultured mixed growths (p = 0.001).
Conclusion: Our findings strongly implicate Staphylococcal epidermidis in the formation of the
pustules seen in acne rosacea. The long history of flushing prior to the appearance of
telangiectasia and pustules, points to the possibility that the persistent flushing produces an
altered environment, which may encourage the growth of Staphylococcus epidermidis and its
subsequent formation of pustules.
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